Home » Bentley Receives Approval to Market Generic Risperidone in Spain
Bentley Receives Approval to Market Generic Risperidone in Spain
Bentley Pharmaceuticals, a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, announced that one of its Spanish subsidiaries, Laboratorios Davur, has received approval to market 1 mg, 3 mg and 6 mg generic dosage versions of risperidone in Spain. Risperidone belongs to a class of antipsychotic products used in the treatment of schizophrenia. The product is marketed by Janssen Pharmaceutica Products, L.P. in the U.S. under the trade name Risperdal.
Yahoo News (http://biz.yahoo.com/bw/050428/285291.html?.v=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May